Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ

Diagn Microbiol Infect Dis. 2012 Dec;74(4):409-11. doi: 10.1016/j.diagmicrobio.2012.08.009. Epub 2012 Sep 10.

Abstract

We present 2 cases of HIV-related cryptococcal meningitis, persisting after 3 and 9 months, respectively, of standard treatment. Both patients were treated successfully with a salvage regimen consisting of the combination of liposomal amphotericin B (3 mg/kg), intravenous voriconazole, and subcutaneous recombinant interferon γ-1b (200 μg thrice weekly). Voriconazole was administered at an increased dose (5 mg/kg, twice daily) to overcome interactions with co-administered ritonavir. In both patients, resolution of clinical signs and symptoms, as well as sterilization of cerebrospinal fluid cultures occurred after 10 weeks of salvage therapy. No major side effects were encountered. At the end of treatment, both patients were placed on maintenance therapy with oral fluconazole; no recurrence has been observed after 4 years of follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Drug Therapy, Combination / methods
  • HIV Infections / complications*
  • Humans
  • Interferon-gamma / administration & dosage*
  • Male
  • Meningitis, Cryptococcal / drug therapy*
  • Middle Aged
  • Pyrimidines / administration & dosage*
  • Salvage Therapy / methods*
  • Treatment Outcome
  • Triazoles / administration & dosage*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • liposomal amphotericin B
  • Amphotericin B
  • Interferon-gamma
  • Voriconazole